Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 11, 2011, Pages

  Capezzone, Marco ^a   Cantara, Silvia ^a   Marchisotta, Stefania ^a   Busonero, Giulia ^a   Formichi, Caterina ^a   Benigni, Michele ^a   Capuano, Serena ^a   Toti, Paolo ^a   Pazaitou Panayiotou, Kalliopi ^b   Caruso, Giuseppe ^a   Carli, Anton Ferdinando ^a   Palummo, Nazzareno ^a   Pacini, Furio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Theageniu Cancer Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER TISSUE; CHEEK MUCOSA; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MUSCLE TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TELOMERE; THYROID ADENOMA; THYROID GLAND; THYROID NODULE; THYROID PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; TELOMERE; THYROID GLAND; THYROID NEOPLASMS;

EID: 80655147234     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1003     Document Type: Article

References (18)

1. Ju Z, Rudolph L 2008 Telomere dysfunction and stem cell ageing. Biochimie (Paris) 90:24-32 (Pubitemid 350216218)
2. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR 2003 Telomere dysfunction: a potential cancer predisposition factor. J Nat Cancer Inst 95:1211-1218 (Pubitemid 37069551)
3. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N 1998 Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58:2117-2125 (Pubitemid 28232897)
4. Broberg K, Björk J, Paulsson K, Höglund M, Albin M 2005 Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 26:1263-1271 (Pubitemid 41417904)
5. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De MarzoAM2004 Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10:3317-3326 (Pubitemid 38685436)
6. Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH, Park JY 2008 Telomere length and the risk of lung cancer. Cancer Sci 99:1385-1389 (Pubitemid 351761728)
7. Kammori M, Takubo K, Nakamura K, Furugouri E, Endo H, Kanauchi H, Mimura Y, Kaminishi M 2000 Telomerase activity and telomere length in benign and malignant human thyroid tissues. Cancer Lett 159:175-181
8. Jones CJ, Soley A, Skinner JW, Gupta J, Haughton MF, Wyllie FS, Schlumberger M, Bacchetti S, Wynford-Thomas D 1998 Dissociation of telomere dynamics from telomerase activity inhumanthyroid cancer cells. Exp Cell Res 240:333-339 (Pubitemid 28371114)
9. Achille M, Boukheris H, Caillou B, Talbot M, de Vathaire F, Sabatier L, Desmaze C, Schlumberger M, Soria JC 2009 Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers. Am J Clin Oncol 32:1-8
10. Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C, Pacini F 2008 Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients, J Clin Endocrinol Metab 93:3950-3957
11. Cawthon RM 2002 Telomere measurement by quantitative PCR. Nucleic Acids Research 30:e47
12. Chiang YJ, Calado RT, Hathcock KS, Lansdorp PM, Young NS, Hodes RJ 2010 Telomere length is inherited with resetting of the telomere set-point. Proc Natl Acad Sci USA 107:10148-10153
13. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips 3rd JA, Lansdorp PM, Greider CW, Loyd JE 2007 Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356:1317-1326 (Pubitemid 46513297)
14. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I 2004 Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36:447-449 (Pubitemid 38620026)
15. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM 2007 Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538-5544 (Pubitemid 46997296)
16. Hills M, Lansdorp PM 2009 Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies. Ann NY Acad Sci 1176:178-190
17. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, Kronenberg F, Kiechl S 2010 Telomere length and risk of incident cancer and cancer mortality. JAMA 304:69-75
18. Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F 2008 Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075-1081